Product image of Nefrosol With Potassium (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc) supplied by GNH India

Nefrosol With Potassium

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Origin:
EU

Nefrosol With Potassium (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium hydrogen carbonate, magnesium chloride hexahydrate, potassium chloride, sodium chloride, calcium, the active ingredient in Nefrosol With Potassium, is an electrolyte solution presented as a solution for injection for intravenous use. It provides electrolyte replacement and helps correct acid‑base imbalances in patients requiring fluid and electrolyte therapy.

GNH India supplies Nefrosol With Potassium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, including intensive care units and surgical suites.

Manufacturer / TM Owner

B.Braun Avitum Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nefrosol With Potassium is an intravenous electrolyte solution used to address disorders of fluid and electrolyte balance.

  • Electrolyte replacement: restores sodium, potassium, magnesium and chloride levels in patients with deficits.
  • Acid‑base correction: supplies bicarbonate ions to help normalize pH in metabolic acidosis.
  • Dehydration with electrolyte loss: replenishes fluids and essential ions after severe vomiting, diarrhea or burns.
  • Post‑operative fluid therapy: maintains electrolyte homeostasis during surgical recovery.

How It Works

  • The solution delivers sodium, potassium, magnesium, calcium and chloride ions directly into the bloodstream, rapidly expanding extracellular fluid volume and restoring osmotic balance. Bicarbonate ions buffer excess hydrogen ions, aiding correction of metabolic acidosis, while the combined electrolytes support cellular function and nerve‑muscle activity.

Side Effects

Nefrosol With Potassium may cause adverse reactions, most of which are related to the infusion process or electrolyte shifts.

Common Side Effects

  • Infusion site irritation: redness or discomfort at the catheter site.
  • Mild hyperkalemia: slight increase in serum potassium.
  • Mild hypernatremia: modest rise in serum sodium.
  • Transient hypotension: temporary drop in blood pressure during infusion.
  • Nausea: occasional upset stomach.
  • Headache: mild headache during or after administration.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous elevation of potassium leading to cardiac arrhythmia.
  • Anaphylactic reaction: rare severe allergic response requiring immediate medical attention.
  • Cardiac arrhythmia: abnormal heart rhythm due to electrolyte imbalance.
  • Metabolic alkalosis: excessive bicarbonate causing high blood pH.
  • Thrombophlebitis: inflammation of the vein with clot formation.
  • Electrolyte overload: fluid and electrolyte excess causing pulmonary edema.

Precautions & Warnings

Before using Nefrosol With Potassium, clinicians should consider several safety measures.

  • Renal impairment: monitor serum electrolytes and adjust infusion rate.
  • Cardiac disease: watch for arrhythmias, especially in patients on other potassium‑affecting drugs.
  • Fluid overload: assess volume status to avoid pulmonary edema.
  • Pregnancy: use only if clearly needed, as safety data are limited.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Nefrosol With Potassium can interact with other medications that affect electrolyte balance.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics: risk of severe hyperkalemia.
  • ACE inhibitors or ARBs: additive increase in serum potassium.
  • Additional sodium bicarbonate solutions: may cause metabolic alkalosis.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may require more frequent electrolyte monitoring.
  • Insulin therapy: insulin drives potassium into cells, potentially lowering serum potassium.
  • Blood transfusions: can alter electrolyte concentrations and require adjustment of infusion rates.

Frequently Asked Questions

Nefrosol With Potassium is an intravenous electrolyte solution used to replace lost electrolytes and correct acid‑base disturbances in patients who require fluid therapy, such as those with dehydration, postoperative needs, or metabolic acidosis.

The formulation supplies sodium, potassium, magnesium, calcium, chloride and bicarbonate ions directly into the bloodstream, rapidly restoring electrolyte concentrations, expanding extracellular fluid volume, and buffering excess hydrogen ions to normalize blood pH.

The prescribed dose is determined by the treating physician based on the patient’s clinical condition, electrolyte levels, and fluid requirements. Dosing is individualized and should follow the prescriber’s instructions.

Safety data in pregnancy and lactation are limited. It should be used only if clearly needed and after a risk‑benefit assessment by the healthcare professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Nefrosol With Potassium combines sodium, potassium, magnesium, calcium and bicarbonate in a single formulation, offering a broader electrolyte profile than many standard saline or potassium‑only solutions, which can simplify fluid management in complex clinical situations.

The product must be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Follow the label instructions to maintain stability and sterility.

It is administered intravenously as a sterile solution for injection. The infusion rate and volume are set by the prescriber and should be monitored by qualified healthcare personnel.

Serious risks include severe hyperkalemia, cardiac arrhythmias, anaphylactic reactions, metabolic alkalosis, and fluid overload leading to pulmonary edema. Immediate medical attention is required if any of these occur.

Patients with known hypersensitivity to any component, uncontrolled hyperkalemia, severe renal failure, or those for whom fluid overload would be hazardous should not receive this product unless a specialist determines it is safe.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.